Insider Trading & Ownership of Longitude Capital Partners III, LLC

Location: Menlo Park, CA
Summary: The estimated value of insider holdings of Longitude Capital Partners III, LLC is at least $70,064,325 dollars as of 29 Apr 2022. Longitude Capital Partners III, LLC is the 10%+ Owner of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $54.72M. Longitude Capital Partners III, LLC is the 10%+ Owner of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. stock worth about $14.9M. Longitude Capital Partners III, LLC is the 10%+ Owner of Sierra Oncology, Inc. and owns shares of Sierra Oncology, Inc. stock worth about $440.8K.
Signature: Longitude Venture Partners III, L.P.; By /s/ Patrick G. Enright, Managing Member of the general partner
All Insider Reports: All Insider Reports

Notify me when Longitude Capital Partners III, LLC files a new Insider Trading report.

Ownership of Longitude Capital Partners III, LLC

Symbol	Company	Relationship	Holdings Value	Report Period
TRML	Talaris Therapeutics, Inc.	10%+ Owner	$54,720,967	11 May 2021
INZY	Inozyme Pharma, Inc.	10%+ Owner	$14,902,533	19 Apr 2022
SRRA	Sierra Oncology, Inc.	10%+ Owner	$440,825	27 Apr 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.